国家神经系统疾病临床医学研究中心数据管理与共享系统

Data Management And Sharing System of China National Clinical Research Center for Neurological Diseases

Validation of the mSOAR and SOAR scores to predict early mortality in Chinese acute stroke patients

第一作者:Hui Wang

通讯作者:Yuesong Pan

mSOAR score Chinese acute stroke patients

基本信息

  • 负责人:Hui Wang
  • 数据来源: CNSR-I
  • 论文编号:CNSR-I20180008
  • 发表时间:2017-07-06

2017-07-06

已发表文章

发表杂志:plos one

发表类型: Original Contributions

影响因子(IF): 3.24

PMID: 0180444 Pubmed原文链接 全文下载

主要研究背景及目的

It is unclear in Chinese patients with acute stroke how the SOAR (stroke subtype, Oxfordshire Community Stroke Project classification, age, and prestrike modified Rankin) and mSOAR (modified-SOAR) scores performed in predicting discharge mortality and 3-month mortality. We aimed to validate the predictability of these scores in this cohort.

方法

Data from the China National Stroke Registry (CNSR) study was used to perform the mSOAR and SOAR scores for predicting the discharge and 3-month mortality in acute stroke patients.

结论

The mSOAR score predicted reliably the risk of death in Chinese acute stroke patients.

主要结果

A total of 11073 acute stroke patients were included in present study. The increased mSOAR and SOAR scores were closely related to higher death risk in acute stroke patients. For discharge mortality, the area under the receiver-operator curve (AUC) of the mSOAR and SOAR scores were 0.784 (95% CI 0.761–0.807) and 0.722 (95% CI: 0.698–0.746). For 3-month mortality, they were 0.787 (95% CI: 0.771–0.803) and 0.704 (95% CI: 0.687–0.721), respectively. The mSOAR and SOAR scores showed significant correlation between the predicted and observed probabilities of discharge mortality (mSOAR: r = 0.945, P = 0.001; SOAR: r = 0.994, P<0.001) and 3-month mortality (mSOAR: r = 0.984, P<0.001; SOAR: r = 0.999; P<0.001).